Therapeutic Differences in 24‐h Ambulatory Blood Pressures in Patients Switched Between Bioequivalent Nifedipine Osmotic Systems With Differing Delivery Technologies

Comparing modified‐release formulations can be difficult using current bioequivalence criteria. Two 60‐mg‐once‐daily nifedipine formulations are deemed bioequivalent in Canada. This study examined the validity of the assumption that these interchangeable, but different, delivery technologies are the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pollak, PT, Herman, RJ, Feldman, RD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421736/
https://www.ncbi.nlm.nih.gov/pubmed/28233944
http://dx.doi.org/10.1111/cts.12442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421736/
https://www.ncbi.nlm.nih.gov/pubmed/28233944
http://dx.doi.org/10.1111/cts.12442

Ejemplares similares